HemOnc Today


The following articles appeared in the print edition of HEMONC TODAY.

Table of Contents

Bevacizumab plus lomustine improved outcomes in recurrent glioblastoma

Mary-Claire King, PhD, receives Lasker medical science award

Cover Story

Multiple TKIs for first-line CML treatment ‘a mixed blessing’


Not again … but I thought the government and Pharma said the problem was fixed?

Derek Raghavan, MD, PhD

Imaging Analysis

CASTLE: Cancer of the thyroid showing thymus-like differentiation

Stephanie L. Lee, MD, PhD, ECNU

In the Journals

White blood cell recovery predicted OS, PFS after HCT

Surgery improved outcomes in advanced laryngeal cancer

Volasertib plus cytarabine extended survival in AML

Multidisciplinary approach may better detect, treat depression among patients with cancer

Contralateral prophylactic mastectomy often used unnecessarily

Researchers identify risk factors for soft tissue necrosis in OSCC

BRCA2 mutation associated with shorter survival in screen-detected prostate cancer

Flexible sigmoidoscopy screening reduced colorectal cancer incidence, mortality

Cancer screenings common among those with shortest life expectancies

Higher BMI increased risk for 10 common cancers

Delayed cord clamping did not affect long-term iron status, neurodevelopment in infants

Malignant bowel obstruction palliative surgery linked to complications, mortality

Persistently negative D-dimers associated with low VTE recurrence

Masitinib superior to sunitinib in advanced GIST

Tigecycline plus piperacillin-tazobactam shows promise for febrile neutropenia

t(14;18) translocation predicted follicular lymphoma development

Lung cancer screening of Medicare-eligible patients associated with greater benefits, risks

Lenalidomide active in recurrent ovarian cancer

Dabrafenib improved quality of life in patients with metastatic melanoma

Docetaxel plus nintedanib effective second-line therapy for NSCLC

Lexaptepid shows promise for anemia of inflammation treatment

Ado-trastuzumab emtansine extended PFS in pretreated HER-2–positive breast cancer

At-risk girls least likely to be offered HPV vaccine

Bevacizumab appears tolerable in cutaneous melanoma

Female sex associated with improved survival in HCC

Laparoscopic colorectal cancer surgery reduced length of hospital stay

Trametinib–dabrafenib combination extended PFS in BRAF-mutated melanoma

PTEN-mutated Cowden disease increased risk for second malignant neoplasms

Institution Notes

UPCI appoints program co-director

AACR presents research award

Cancer center names director of BMT

Nursing assistant receives award

Letters to the Editor

'Conjectural statement' could cause confusion about 340B program

Meeting News Coverage

Adjuvant chemotherapy extended OS, DFS in luminal B breast cancer

PET/MR improved detection of metastases in breast cancer

Breast reconstruction complications higher among women who underwent bilateral mastectomy

Post-progression data rarely reported in phase 3 metastatic breast cancer trials

Veliparib active in BRCA-mutated breast cancer

Aspirin, NSAIDs reduced risk for aggressive prostate cancer

Obesity, inflammation during adolescence increased colorectal cancer later in life

Pertuzumab conferred ‘unprecedented’ OS benefit in HER-2–positive metastatic breast cancer

Radiation may replace axillary lymph node dissection after SLNB-detected N1 disease

Addition of chemotherapy to radiation failed to improve outcomes in esophageal cancer

High-dose radiation plus long-term ADT extended survival in prostate cancer

Novel vaccine benefitted high-risk patients with HER-2 overexpression

Crizotinib shows promise in ROS1-rearranged advanced NSCLC

Patients with advanced pancreatic NET achieved 44-month OS with Afinitor

BCT increasingly used, but barriers persist

Margin status not linked to recurrence, survival in DCIS

Rivaroxaban reduced VTE recurrence, major bleeding in patients with cancer

Surgical excision may be avoidable for classic lobular neoplasia